3D Printed Micro-Optics to the Market
The 3DPrintoptixMarket project aims to commercialize innovative 3D printed micro-optics for AR/VR applications, partnering with Viewpointsystem to develop a cost-effective demonstrator for a rapidly growing market.
Projectdetails
Introduction
In the project 3DPrintoptixMarket, we are going to take 3D printed micro-optics to the market. The technology had been developed in the framework of PoC grant 3DPRINTEDOPTICS by the group of Harald Giessen, who had published key papers on this technology and who founded the company Printoptix GmbH as an outcome.
Project Goals
We are going to build complex 3D printed multiplet micro-lenses for augmented, virtual, and mixed reality (AR/VR/MR) applications. This market is growing at more than a 40% annual rate, projected to reach a market size of over 300 billion USD by the year 2028.
Collaboration
For this purpose, we are teaming up with Printoptix and one of the leading eye tracking companies, Viewpointsystem GmbH from Vienna. Together, we will develop a first industrially viable demonstrator that integrates 3D printed micro-optics into their AR/VR goggles to read out the eye pupil position upon infrared illumination.
Target Customers
We are going to take this technology demonstrator to early customers who use such systems for:
- Remote repair
- Remote advice
- Customer training and monitoring
Upon success, our technology will be introduced to larger customers that address the giant AR/VR/MR market, which includes:
- Teleconferencing
- Remote medicine
- Servicing and training
- Gaming
Business Model Exploration
Simultaneously, we are going to explore viable business models for 3D printed micro-optics and address key business numbers such as:
- Manufacturing cost per part
- Overhead
- Investments
One key part of our proposal is to lower the cost per part to reach numbers below existing technologies. Furthermore, we are going to prepare a business plan to get 3D printed micro-optics investor-ready.
Conclusion
This will assure that our world-leading, disruptive 3D printed micro-optics technology provides unique high-tech solutions for global markets, which are currently not addressed by Asian or American companies. This will therefore be a hallmark example of “Made in Europe” high technology.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.496.602 |
Totale projectbegroting | € 2.496.962 |
Tijdlijn
Startdatum | 1-6-2023 |
Einddatum | 31-5-2026 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- PRINTOPTIX GMBHpenvoerder
- VIEWPOINTSYSTEM GMBH
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Printing Electro-TomographyThe project aims to enhance 3D printing by integrating real-time electrical impedance measurements for improved speed and precision, boosting quality and efficiency in both professional and consumer markets. | ERC POC | € 150.000 | 2022 | Details |
Diffractive Optical Element Fabrication based on 3D PrintingThe project aims to revolutionize Diffractive Optical Element fabrication by adapting a 3D printing method for solid DOEs, reducing costs and production time while enhancing accessibility. | ERC POC | € 150.000 | 2023 | Details |
Mass Manufacturing Augmented Reality (AR) Waveguides via Roll-to-Plate NanoimprintingMorphotonics aims to validate and mature its patented Roll-to-Plate nanoimprinting technology for low-cost AR waveguides, while establishing a European foundry to enhance local production sovereignty. | EIC Accelerator | € 2.458.662 | 2023 | Details |
Shedding light on a new 3D metal printing techniqueMeltify ontwikkelt een kostenefficiënte 3D metaalprinter met LED-technologie om de productie te versnellen en kosten te verlagen, gericht op diverse sectoren en groei van werkgelegenheid. | MIT Haalbaarheid | € 20.000 | 2022 | Details |
Printing Electro-Tomography
The project aims to enhance 3D printing by integrating real-time electrical impedance measurements for improved speed and precision, boosting quality and efficiency in both professional and consumer markets.
Diffractive Optical Element Fabrication based on 3D Printing
The project aims to revolutionize Diffractive Optical Element fabrication by adapting a 3D printing method for solid DOEs, reducing costs and production time while enhancing accessibility.
Mass Manufacturing Augmented Reality (AR) Waveguides via Roll-to-Plate Nanoimprinting
Morphotonics aims to validate and mature its patented Roll-to-Plate nanoimprinting technology for low-cost AR waveguides, while establishing a European foundry to enhance local production sovereignty.
Shedding light on a new 3D metal printing technique
Meltify ontwikkelt een kostenefficiënte 3D metaalprinter met LED-technologie om de productie te versnellen en kosten te verlagen, gericht op diverse sectoren en groei van werkgelegenheid.